0001127602-12-023572.txt : 20120802 0001127602-12-023572.hdr.sgml : 20120802 20120802160706 ACCESSION NUMBER: 0001127602-12-023572 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120731 FILED AS OF DATE: 20120802 DATE AS OF CHANGE: 20120802 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: QUEST DIAGNOSTICS INC CENTRAL INDEX KEY: 0001022079 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 161387862 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3 GIRALDA FARMS CITY: MADISON STATE: NJ ZIP: 07940 BUSINESS PHONE: 9735202700 MAIL ADDRESS: STREET 1: 3 GIRALDA FARMS CITY: MADISON STATE: NJ ZIP: 07940 FORMER COMPANY: FORMER CONFORMED NAME: CORNING CLINICAL LABORATORIES INC DATE OF NAME CHANGE: 19960903 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PREVOZNIK MICHAEL E CENTRAL INDEX KEY: 0001222679 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12215 FILM NUMBER: 121003506 MAIL ADDRESS: STREET 1: 3 GIRALDA FARMS CITY: MADISON STATE: NJ ZIP: 07940 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2012-07-31 0001022079 QUEST DIAGNOSTICS INC DGX 0001222679 PREVOZNIK MICHAEL E C/O QUEST DIAGNOSTICS INCORPORATED 3 GIRALDA FARMS MADISON NJ 07940 1 SVP & General Counsel Common Stock 2012-07-31 4 M 0 28814 24.76 A 65435 D Common Stock 2012-07-31 4 S 0 28814 58.592 D 36621 D Common Stock 2012-07-31 4 M 0 11408 24.76 A 48029 D Common Stock 2012-08-01 4 M 0 31778 24.76 A 79807 D Common Stock 2012-08-01 4 M 0 54667 52.235 A 134474 D Common Stock 2012-08-01 4 S 0 86445 58.6766 D 48111 D Common Stock 4393 I 401k/SDCP Stock Options (Right to Buy) 24.76 2012-07-31 4 M 0 28814 0 D 2013-02-13 Common Stock 28814 43186 D Stock Options (Right to Buy) 24.76 2012-07-31 4 M 0 11408 0 D 2013-02-13 Common Stock 11408 31778 D Stock Options (Right to Buy) 24.76 2012-08-01 4 M 0 31778 0 D 2013-02-13 Common Stock 31778 0 D Stock Options (Right to Buy) 52.235 2012-08-01 4 M 0 54667 0 D 2013-02-15 Common Stock 54667 0 D This transaction was executed in multiple trades at prices ranging from $58.40 to $58.77. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $58.25 to $59.03. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The amount includes approximately 30 shares acquired via dividend reinvestment since the date of the last filing on Form 4 pursuant to a dividend reinvestment plan, sponsored by a broker-dealer, that essentially mirrors a dividend reinvestment plan sponsored by the registrant. The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k) and/or Supplemental Deferred Compensation Plan. The information was obtain from the plan administrator as of a recent date. The number of shares is based on the account balance of the Company stock fund under the plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date. The options vested in three installments beginning with the first on February 13, 2004, the second on February 13, 2005 and the final on February 13, 2006. The options vested in three installments beginning with the first on February 15, 2007, the second on February 15, 2008 and the final on February 15, 2009. /s/ William J. O'Shaughnessy, Jr., Attorney in Fact for Michael E. Prevoznik 2012-08-02